Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Jan 28, 2009; 15(4): 449-456
Published online Jan 28, 2009. doi: 10.3748/wjg.15.449
Published online Jan 28, 2009. doi: 10.3748/wjg.15.449
Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
Markus Moehler, Martin F Sprinzl, Carl C Schimanski, Andreas Teufel, Juergen Siebler, Peter R Galle, 1st Medical Department, Johannes Gutenberg-University, Langenbeckstrasse 1, 55116 Mainz, Germany
Murad Abdelfattah, Bernd Adami, Outpatient Clinic, Spiessgasse 58b, 55232 Alzey, Germany
Werner Godderz, Outpatient Clinic, Bahnhofplatz 2, 55116 Mainz, Germany
Klaus Majer, Outpatient Clinic of City Hospital, Kapuzinerstrasse 15, 55411 Bingen, Germany
Dimitri Flieger, Outpatient Clinic of City Hospital, GPR Klinikum, 65423 Rüsselsheim, Germany
Thomas Hoehler, Outpatient Clinic of 1st Medical Department, Mühlenstrasse 27, 45659 Recklinghausen, Germany
Stephan Kanzler, Outpatient Clinic of 2nd Medical Department, Leopoldina Krankenhaus, Gustaf Adolf Strasse 8, 97422 Schweinfurt, Germany
Author contributions: Moehler M and Sprinzl MF contributed equally to the preparation of the manuscript; Moehler M and Kanzler S designed the study proposal; All authors treated the patients, collected and provided patients data; Moehler M, Sprinzl MF and Abdelfattah M analyzed the data and wrote the paper.
Supported by The companies Pfizer and Roche provided partial support for the study and data monitoring
Correspondence to: Markus Moehler, MD, 1st Medical Department, Johannes Gutenberg-University, Langenbeckstrasse 1, 55116 Mainz, Germany. moehler@mail.uni-mainz.de
Telephone: +49-6131-176839
Fax: +49-6131-176410
Received: September 23, 2008
Revised: December 16, 2008
Published online: January 28, 2009
Revised: December 16, 2008
Published online: January 28, 2009
Core Tip